 Homozygous -thalassemia is still a lethal disease when treated inadequately. An intensive supportive care of these patients with blood transfusion and hemosiderosis prophylaxis with desferal remains to be essential. A sicilian patient, diagnosed to have a homocygote -thalassemia at the age of 9 months, inconsistent developed severe complications, such as hemosiderosis, dystrophia, skeletal deformations, and failures of other organ systems. Caused by an inconsistent therapy. The patient died aged 20 years from hemosiderosis dependent cardiomyopathy. Together with this case, the actual therapy regimens are reviewed and future therapy modalities are discussed.  
